Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype

Abstract

Inflammatory breast cancer (IBC) is the most aggressive and distinct form of primary breast cancer with a peculiar clinical presentation and dismal clinical outcome. This review addresses the pathologic aspects of this entity and discusses the molecular alterations involved in the highly malignant phenotype of IBC.